HRS-4029

DRUG2 trials

Sponsors

Beijing Suncadia Pharmaceuticals Co., Ltd

Conditions

Acute Ischemic Stroke

Phase 1

A Single Ascending Dose of HRS-4029 in Healthy Subjects

Not yet recruitingNCT06905314

Beijing Suncadia Pharmaceuticals Co., LtdAcute Ischemic Stroke

Start: 2025-04-30End: 2025-12-31Target: 55Updated: 2025-04-01

Phase 2

The Efficacy and Safety of HRS-4029 in Acute Ischemic Stroke Patients

Not yet recruitingNCT07739160

Beijing Suncadia Pharmaceuticals Co., LtdAcute Ischemic Stroke

Start: 2026-08-15End: 2027-07-31Target: 340Updated: 2026-07-31